Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Loewald Thomas W, Director. Officer active across 2 companies, notably HARVARD BIOSCIENCE INC. In total, 6 disclosures have been logged. Activity tracked since 25 May 2021. The latest transaction was disclosed on 21 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Thomas W. Loewald is a Board Member at Harvard Bioscience Inc. He plays a key role in the governance of the company, contributing to strategy and decision-making. His experience in the biopharmaceutical sector is valuable in guiding Harvard Bioscience in its development and innovation initiatives.